                         SEQUENCE LISTING

<110>  VITO NV
       Universiteit Antwerpen
 
<120>  IMMUNOTHERAPY MARKERS

<130>  VITO-003

<150> EP19197602.6
<151> 2019-09-16

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  30
<212>  PRT
<213>  Homo sapiens

<400>  1

Ala Cys Tyr Cys Arg Ile Pro Ala Cys Ile Ala Gly Glu Arg Arg Tyr 
1               5                   10                  15      


Gly Thr Cys Ile Tyr Gln Gly Arg Leu Trp Ala Phe Cys Cys 
            20                  25                  30  


<210>  2
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  2

Cys Tyr Cys Arg Ile Pro Ala Cys Ile Ala Gly Glu Arg Arg Tyr Gly 
1               5                   10                  15      


Thr Cys Ile Tyr Gln Gly Arg Leu Trp Ala Phe Cys Cys 
            20                  25                  


<210>  3
<211>  30
<212>  PRT
<213>  Homo sapiens

<400>  3

Asp Cys Tyr Cys Arg Ile Pro Ala Cys Ile Ala Gly Glu Arg Arg Tyr 
1               5                   10                  15      


Gly Thr Cys Ile Tyr Gln Gly Arg Leu Trp Ala Phe Cys Cys 
            20                  25                  30  


